Table 3.

ART and adverse event related characteristics of patients that were LTFU compared to those that remained in care, Tshepang Pharmacovigilance cohort, 2004-2012

Variable		Total		LTFU		In care		χ2
		N	%	n	(%)	n	%	p - value
Initiating regimen	d4t containing*	581	98.3	443	98.0	138	99.3	0.466
4missing	Other	10	1.7	9	2.00	139	0.7
Alcohol	No	468	82.4	107	82.95	361	82.2	0.852
27 missing	Yes	100	17.6	22	17.05	78	7.8
Adverse events	No	251	44.3	67	51.5	184	42.1	0.057
28 missing	Yes	316	55.7	63	48.5	253	57.9

*d4t – stavudine